G1 Therapeutics Price on July 11, 2024
| GTHXDelisted Stock | USD 7.15 0.00 0.00% |
If you're considering investing in GTHX Stock, it is important to understand the factors that can impact its price. As of today, the current price of G1 Therapeutics stands at 7.15, as last reported on the 1st of December, with the highest price reaching 7.16 and the lowest price hitting 7.14 during the day. At this stage we consider GTHX Stock to be very steady. G1 Therapeutics retains Efficiency (Sharpe Ratio) of 0.38, which attests that the company had a 0.38% return per unit of price deviation over the last 3 months. We have found twenty-six technical indicators for G1 Therapeutics, which you can use to evaluate the volatility of the entity. Please check out G1 Therapeutics' Market Risk Adjusted Performance of (1.95), standard deviation of 8.77, and Semi Deviation of 1.98 to validate if the risk estimate we provide is consistent with the expected return of 0.0704%.
GTHX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
GTHX |
Sharpe Ratio = 0.3804
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | GTHX | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.19 actual daily | 1 99% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.38 actual daily | 29 71% of assets perform better |
Based on monthly moving average G1 Therapeutics is performing at about 29% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of G1 Therapeutics by adding it to a well-diversified portfolio.
Related Headline
Amylyx Pharmaceuticals Headline on 11th of July 2024
Amylyx Pharmaceuticals Buy Rating Reaffirmed at HC Wainwrigh... by news.google.com
Amylyx Pharmaceuticals Buy Rating Reaffirmed at HC Wainwright Defense World
G1 Therapeutics Valuation on July 11, 2024
It is possible to determine the worth of G1 Therapeutics on a given historical date. On July 11, 2024 GTHX was worth 2.85 at the beginning of the trading date compared to the closed value of 2.99. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of G1 Therapeutics stock. Still, in general, we apply an absolute valuation method to find G1 Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of G1 Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against G1 Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.68 | 2.80 | 2.61 | 2.79 | 430,638 | |
07/11/2024 | 2.85 | 3.06 | 2.83 | 2.99 | 1,093,222 |
| 3.05 | 3.21 | 2.99 | 3.19 | 1,270,649 |
| Backtest G1 Therapeutics | | | G1 Therapeutics History | | | G1 Therapeutics Valuation | Previous | Next |
G1 Therapeutics Trading Date Momentum on July 11, 2024
| On July 12 2024 G1 Therapeutics was traded for 3.19 at the closing time. The top price for the day was 3.21 and the lowest listed price was 2.99 . The trading volume for the day was 1.3 M. The trading history from July 12, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 6.69% . The overall trading delta against the current closing price is 22.41% . |
G1 Therapeutics Fundamentals Correlations and Trends
By evaluating G1 Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among G1 Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GTHX financial account trend analysis is a perfect complement when working with valuation or volatility modules.About G1 Therapeutics Stock history
G1 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GTHX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in G1 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing G1 Therapeutics stock prices may prove useful in developing a viable investing in G1 Therapeutics
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. G1 Therapeutics, Inc. was incorporated in 2008 and is headquartered in Research Triangle Park, North Carolina. G1 Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 148 people.
G1 Therapeutics Stock Technical Analysis
G1 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
G1 Therapeutics Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
G1 Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
G1 Therapeutics December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how G1 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading G1 Therapeutics shares will generate the highest return on investment. By undertsting and applying G1 Therapeutics stock market strength indicators, traders can identify G1 Therapeutics entry and exit signals to maximize returns
G1 Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for G1 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of GTHX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GTHX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1498 | |||
| Jensen Alpha | 1.71 | |||
| Total Risk Alpha | 0.1395 | |||
| Sortino Ratio | 0.4149 | |||
| Treynor Ratio | (1.96) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in GTHX Stock
If you are still planning to invest in G1 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G1 Therapeutics' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |